See more : Renesas Electronics Corporation (RNECY) Income Statement Analysis – Financial Results
Complete financial analysis of Mednow Inc. (MNOW.V) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Mednow Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Asian Tea and Exports Ltd. (ASIANTNE.BO) Income Statement Analysis – Financial Results
- Powszechny Zaklad Ubezpieczen SA (PZU.WA) Income Statement Analysis – Financial Results
- Suzhou Xianglou New Material Co., Ltd. (301160.SZ) Income Statement Analysis – Financial Results
- Aktia Pankki Oyj (AKTIA.HE) Income Statement Analysis – Financial Results
- Voquz Labs AG (VQLA.VI) Income Statement Analysis – Financial Results
Mednow Inc. (MNOW.V)
About Mednow Inc.
Mednow Inc., a healthcare company, develops and operates a proprietary web and mobile application to facilitate the sale and distribution of prescription medications and the delivery of virtual care, telemedicine services, and doctor home visits in Canada. It also owns and operates retail pharmacies located in British Columbia, Manitoba, Ontario, and Nova Scotia. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.
| Metric | 2022 | 2021 | 2020 |
|---|---|---|---|
| Revenue | 16.64M | 414.00K | 0.00 |
| Cost of Revenue | 13.86M | 0.00 | 0.00 |
| Gross Profit | 2.78M | 414.00K | 0.00 |
| Gross Profit Ratio | 16.73% | 100.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 |
| General & Administrative | 19.84M | 8.31M | 385.94K |
| Selling & Marketing | 2.82M | 896.51K | 83.56K |
| SG&A | 22.66M | 9.21M | 469.50K |
| Other Expenses | 23.40K | 0.00 | 0.00 |
| Operating Expenses | 24.42M | 9.41M | 469.50K |
| Cost & Expenses | 38.28M | 9.41M | 469.50K |
| Interest Income | 158.35K | 50.09K | 0.00 |
| Interest Expense | 188.51K | 815.00 | 0.00 |
| Depreciation & Amortization | 1.76M | 201.35K | 206.30K |
| EBITDA | -19.85M | -8.75M | -469.50K |
| EBITDA Ratio | -119.28% | -2,113.93% | 0.00% |
| Operating Income | -21.61M | -8.95M | -469.50K |
| Operating Income Ratio | -129.86% | -2,162.57% | 0.00% |
| Total Other Income/Expenses | -10.38M | -156.60K | 0.00 |
| Income Before Tax | -30.07M | -8.95M | -469.50K |
| Income Before Tax Ratio | -180.73% | -2,162.76% | 0.00% |
| Income Tax Expense | -515.96K | -3.71K | 0.00 |
| Net Income | -29.48M | -8.95M | -469.50K |
| Net Income Ratio | -177.20% | -2,162.76% | 0.00% |
| EPS | -1.37 | -0.49 | -0.02 |
| EPS Diluted | -1.37 | -0.49 | -0.02 |
| Weighted Avg Shares Out | 21.57M | 18.40M | 21.60M |
| Weighted Avg Shares Out (Dil) | 21.57M | 18.40M | 21.60M |
Source: https://incomestatements.info
Category: Stock Reports